- Preface
- 1. An Introduction to Advanced Aseptic Processing Technology
- 2. Getting Started, Establishing an Aseptic Processing Systems Technology Group
- 3. Aseptic Processing Facility Design
- 4. Innovations in Aseptic Processing Technology
- 5. Ergonomics in Enclosure Design
- 6. Design & Engineering of Enclosures for Containment Applications
- 7. Design and Engineering of Isolators
- 8. Definition of Restricted Access Barrier Systems
- 9. Rapid Transfer Port Systems
- 10. Aseptic Processing Transfer Systems
- 11. Disposable Equipment in Aseptic Technology
- 12. A Comparison of Capital and Operating Costs for Aseptic Manufacturing Facilities
- 13. Risk Assessment and Mitigation in Aseptic Processing
- 14. Sterile Product Manufacture Using Form Fill Seal Technologies
- 15. Genesis of the Closed Vial Technology
- 16. Aseptic Containment
- 17. Points to Consider - Filling Isolator
- 18. Sterility Test Isolators- A User’s Perspective
- 19. Advanced Aseptic Processing Fill Finish Trends
- 20. Process Simulation for Advanced Aseptic Processing
- 21. Qualification / Validation of Aseptic Processing Environments, Systems & Equipment
- 22. Isolator Integrity Leak Inspection
- 23. Environmental Monitoring of Advanced Aseptic Processing
- 24. Decontamination of Advanced Aseptic Processing Environments
- 25. Hydrogen Peroxide Gas Decontamination
- 26. Isolation Technology: Hydrogen Peroxide Decontamination
- 27. Single Injection Vapor Phase Hydrogen Peroxide Decontamination of Isolators and Cleanrooms
- 28. Chlorine Dioxide Decontamination / Sterilization
- 29. FDA Regulatory Perspective
- 30. The Evolution of Advanced Aseptic Processing for Pharmaceutical Manufacturing: Perspectives of a Regulatory Scientist
- 31. A Perspective on European Regulations for Advanced Aseptic Processing
- 32. Advanced Aseptic Processing Technologies in Japan
- 33. Pilot Plants and Isolation Technology
- 34. High Speed Aseptic Filling
- 35. Kit Assembly
- 36. Radiopharmaceutical Filling Line
- 37. Powder handling installation for high potent bulk pharmaceutical ingredients
- 38. Isolator Technology for Aseptic Filling of Anti-Cancer Drugs
- 39. RABS Case Study
- 40. Innovation in Aseptic Processing: Case Study through the Development of a New Technology
- 41. Isolated Robotics
- 42. The Future of Aseptic Processing
James Agalloco is President of Agalloco & Associates. Since the formation of Agalloco & Associates in 1991, Jim has assisted more than 100 firms in the areas of validation, sterilization, aseptic processing and compliance. . He is a past President of the Parenteral Drug Association and a member of United States Pharmacopeia’s Microbiology and Sterility Assurance Expert Committee since 2005. He has authored or co-authored 43 book chapters and over 100 papers, and has lectured extensively on process validation, aseptic processing, sterilization and isolation technology at various industry meetings, domestically as well as internationally. He also co-edited the book Validation of Pharmaceutical Processes, 3rd edition, Informa Healthcare, 2007.
James E. Akers Ph.D. is President and Co-Owner of Akers Kennedy & Associates and a Technical Consultant to Shibuya Kogyo, Co. LTD. Dr Akers received his BA in Biology from the University of Kansas in 1971 and his Ph.D. in Medical Microbiology from the University of Kansas, School of Medicine in 1976. He is past president of the Parenteral Drug Association (PDA) and has participated on many PDA Task Forces. He has written over 100 articles and 28 book chapters on subjects including aseptic processing, validation, biologics manufacturing, isolation technology, and environmental monitoring. Dr Akers is a Chairman of the Microbiology and Sterility Assurance Committee of Experts for the United States Pharmacopeia and has 35 years of experience working in, evaluating and providing design input for clean environments used in research and manufacturing applications.

